5 October 2018: According to a report by Grand View Research, Inc., the worldwide anesthesia and respiratory devices market is likely to reach USD 26.8 billion by 2022. Anesthesia and respiratory devices are widely used during almost all surgeries and treating respiratory diseases.
On September 17, 2017, Masimo received FDA 510(k) clearance for new product Rad-97 pulse co-oximeter and introduced the device in the US. The product comprises noninvasive blood pressure monitoring technology, continuous monitoring and SET pulse oximetry, and NomoLine capnography. It also encompasses a small footprint and easy configuration, a multi-touch dispaly, Masimo touted, with built-in enterprise Bluetooth and WiFi support to connect compatible devices such as weight scales, glucometers, and thermometers. It can be used in many healthcare environments like alternate care, lower-acuity settings in hospitals, telehealth, and other.
Royal Philips launched its new and small positive airway pressure (PAP) device named DreamStation Go. This device can be beneficial for patients suffering from obstructive sleep apnea (OSA). The device is developed to complete travelling patient’s requirements. The product is available in auto-titrated APAP model as well as fixed-pressure continuous positive airway pressure (CPAP). Both models are facilitated with Bluetooth and can be linked with Philips’ EncoreAnywhere, which can help user to monitor therapy performance across several devices from one shared dashboard. It can be also united with care Orchestrator cloud-based patient management systems for clinicians.
Factors such as growing elderly population, increasing occurrence respiratory complaints including obstructive sleep apnea (OSA) and chronic obstructive pulmonary disease (COPD), and increasing environmental pollution can propel anesthesia and respiratory devices market during the forecast period (2012 to 2022).
However, high costs of these devices and availability of alternate medications may restrict the market growth during the forecast period.
North America has been dominating the market due to availability of the developed healthcare infrastructure and high awareness among the people.
Some of the leading players operating in the market include Draegerwerk AG, GE Healthcare, Smith Medicals, Philips Healthcare, and Fisher and Paykel.
Read more @
https://www.grandviewresearch.com/industry-analysis/anesthesia-and-respiratory-devices-market
On September 17, 2017, Masimo received FDA 510(k) clearance for new product Rad-97 pulse co-oximeter and introduced the device in the US. The product comprises noninvasive blood pressure monitoring technology, continuous monitoring and SET pulse oximetry, and NomoLine capnography. It also encompasses a small footprint and easy configuration, a multi-touch dispaly, Masimo touted, with built-in enterprise Bluetooth and WiFi support to connect compatible devices such as weight scales, glucometers, and thermometers. It can be used in many healthcare environments like alternate care, lower-acuity settings in hospitals, telehealth, and other.
Royal Philips launched its new and small positive airway pressure (PAP) device named DreamStation Go. This device can be beneficial for patients suffering from obstructive sleep apnea (OSA). The device is developed to complete travelling patient’s requirements. The product is available in auto-titrated APAP model as well as fixed-pressure continuous positive airway pressure (CPAP). Both models are facilitated with Bluetooth and can be linked with Philips’ EncoreAnywhere, which can help user to monitor therapy performance across several devices from one shared dashboard. It can be also united with care Orchestrator cloud-based patient management systems for clinicians.
Factors such as growing elderly population, increasing occurrence respiratory complaints including obstructive sleep apnea (OSA) and chronic obstructive pulmonary disease (COPD), and increasing environmental pollution can propel anesthesia and respiratory devices market during the forecast period (2012 to 2022).
However, high costs of these devices and availability of alternate medications may restrict the market growth during the forecast period.
North America has been dominating the market due to availability of the developed healthcare infrastructure and high awareness among the people.
Some of the leading players operating in the market include Draegerwerk AG, GE Healthcare, Smith Medicals, Philips Healthcare, and Fisher and Paykel.
Read more @
https://www.grandviewresearch.com/industry-analysis/anesthesia-and-respiratory-devices-market
1 comment:
For people with COPD, asthma, Congestive Heart Failure (CHF) and other conditions, pulse oximetry is a technology used to measure the oxygen level in your blood and your heart rate. A finger pulse oximeter is equipped with technology to rapidly detect changes in your blood oxygen level.
Post a Comment